Dr. rer. nat. Yun Zhang

List of publications:

BibTeX-Download


Department of Medicine 3 – Rheumatology and Immunology Interdisziplinäres Zentrum für Klinische Forschung IZKF-Förderlinien
close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis (2017) Bergmann C, Brandt A, Merlevede B, Hallenberger L, Dees C, Wohlfahrt T, Pötter S, et al. Journal article Jumonji Domain Containing Protein 3 (JMJD3) As a Novel Epigenetic Mechanism of Fibroblast Activation By Regulation of Fra-2 (2016) Bergmann C, Brandt A, Dees C, Zhang Y, Lin NY, Chen CW, Mallano T, et al. Conference contribution Dipeptidyl-Peptidase-4 (DPP4) Positive Fibroblast Subpopulation Promotes Fibrosis and Are a Molecular Target for Treatment of Fibrosis (2016) Soare A, Rauber S, Wohlfahrt T, Dees C, Liang R, Zhang Y, Chen CW, et al. Conference contribution WNT5A PROMOTES FIBROBLAST ACTIVATION AND TISSUE FIBROSIS BY ROR2/RYK DEPENDENT ACTIVATION OF PCP-SIGNALING (2016) Chen CW, Lin NY, Zhang Y, Huang J, Palumbo-Zerr K, Schambony A, Beyer C, et al. Conference contribution The transcription factor GLI2 as a downstream mediator of transforming growth factor-?-induced fibroblast activation in SSc (2016) Liang R, Sumova B, Cordazzo C, Mallano T, Zhang Y, Wohlfahrt T, Dees C, et al. Journal article Inhibition of casein kinase II reduces TGF? induced fibroblast activation and ameliorates experimental fibrosis (2015) Zhang Y, Dees C, Beyer C, Lin NY, Distler A, Zerr P, Palumbo K, et al. Journal article Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis (2015) Huang J, Beyer C, Palumbo-Zerr K, Zhang Y, Distler A, Gelse K, Distler O, et al. Journal article Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages (2015) Beyer C, Huang J, Beer J, Zhang Y, Palumbo-Zerr K, Zerr P, Distler A, et al. Journal article Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability (2014) Distler A, Lang V, Del Vecchio T, Huang J, Zhang Y, Beyer C, Lin NY, et al. Journal article
‹ 1 2 3 ›